SCHEMBL18753852

SCHEMBL18753852

Cc1cc(C(=O)N2CCN(C(=O)c3ccncc3F)CC2)ccc1N[SH](=O)=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.45
▸ MYC P01106 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ABL1 P00519 3/20 0.39
▸ BCR P11274 3/20 0.39
▸ ATR Q13535 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LRRK2 Q5S007 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAP3K7 O43318 1/20 0.36
▸ GHSR Q92847 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CPS1 P31327 1/20 0.36
▸ PKLR P30613 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753827 0.88 LRRK2 (0.43) MYCMEN1KMT2AHPGDALDH1A1
SCHEMBL22422552 0.87 POLB (0.46) POLBMYCMEN1KMT2AABL1
SCHEMBL18753335 0.87 LMNA (0.47) POLBLRRK2TSHRMAP3K7CPS1
SCHEMBL18753307 0.85 TSHR (0.47) POLBHPGDALDH1A1L3MBTL1TSHR
SCHEMBL18753748 0.85 RBP4 (0.47) POLBMYCABL1BCRHPGD
SCHEMBL18753487 0.85 ALDH1A1 (0.54) POLBKMT2AABL1BCRHPGD
SCHEMBL18753811 0.83 PKM (0.55) POLBMYCMEN1KMT2AABL1
SCHEMBL20750502 0.82 POLB (0.50) POLBABL1BCRALDH1A1L3MBTL1
SCHEMBL18753318 0.82 KMT2A (0.59) POLBMEN1KMT2AABL1BCR
SCHEMBL18753484 0.82 MYC (0.54) MYCMEN1KMT2AABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2020-01-29 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback